Aijun Ma
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Circular RNAs in diseases 7
- Extracellular vesicles in disease 5
- Inflammasome and immune disorders 3
-
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 4
- Co-authors
- Xudong Pan (26 shared papers)Shaonan Yang (16 shared papers)Ruihua Yin (8 shared papers)Xiaoyan Zhu (8 shared papers)Juanjuan Ma (3 shared papers)Na Li (2 shared papers)Anmu Xie (2 shared papers)Jingli Zhang (1 shared paper)
- Journals
- International Immunopharmacology (2 papers)Clinica Chimica Acta (2 papers)Neuroreport (1 paper)Clinical Neurology and Neurosurgery (1 paper)BioMed Research International (1 paper)
- Partner nations
- China
In The Last Decade
Aijun Ma
33 papers receiving 693 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 281
- Immunology 143
- Molecular Biology 385
- Neurology 37
- Epidemiology 100
Countries citing papers authored by Aijun Ma
This map shows the geographic impact of Aijun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Ma more than expected).
Fields of papers citing papers by Aijun Ma
This network shows the impact of papers produced by Aijun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Ma. The network helps show where Aijun Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Aijun Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 94 | |
| 2 | 2020 | 69 | |
| 3 | 2019 | 53 | |
| 4 | 2018 | 53 | |
| 5 | 2018 | 34 | |
| 6 | 2019 | 34 | |
| 7 | 2014 | 32 | |
| 8 | 2018 | 31 | |
| 9 | 2020 | 30 | |
| 10 | 2017 | 29 | |
| 11 | 2016 | 23 | |
| 12 | 2015 | 22 | |
| 13 | 2017 | 22 | |
| 14 | 2021 | 20 | |
| 15 | 2018 | 18 | |
| 16 | 2018 | 18 | |
| 17 | 2021 | 18 | |
| 18 | 2013 | 12 | |
| 19 | 2017 | 12 | |
| 20 | 2016 | 11 |
About Aijun Ma
Aijun Ma is a scholar working on Molecular Biology, Cancer Research, Immunology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 696 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers), Extracellular vesicles in disease (5 papers), Autophagy in Disease and Therapy (5 papers), Cancer-related molecular mechanisms research (4 papers), Inflammasome and immune disorders (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Cancer Research (281 citations), Immunology (143 citations), Molecular Biology (385 citations), Neurology (37 citations) and Epidemiology (100 citations). Aijun Ma has collaborated with scholars based in China. Frequent co-authors include Xudong Pan, Shaonan Yang, Ruihua Yin, Xiaoyan Zhu, Juanjuan Ma, Na Li, Anmu Xie, Jingli Zhang, Yuan Wang and Shuna Yang. Their work appears in journals such as International Immunopharmacology, Clinica Chimica Acta, Neuroreport, Clinical Neurology and Neurosurgery and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.